Perrigo have been marketing ACR's HRT product in the US(?) for years, Giedion Richter in EU. But that doesn't stop a drug coy from challenging patients... no matter who they have deals with. I don't think it will be our Jublia Generic as Perrigo has it's own ANDA for Jublia submitted with the FDA .... along with some 13 others.
1. I would love to know how the 6 TruPhama Dossiers are going- market sales of near US400 million a year, supposedly 2. how the Amring Dossier is going market sales of near US$440 million a year, supposedly 3. who our new Elma Cream partner is market sales not worth talking about 4. and Dapsol Gel 5% who our partner is also not worth talking about
so ACR has now hinted about 8 products with signed deals. the 3rd deal signed in the past days..... and we still know nothing about the other 2.
ACR Price at posting:
6.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)